Should Biotechnology Stock Adagio Therapeutics Inc (ADGI) Be in Your Portfolio Wednesday?

Wednesday, January 19, 2022 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Adagio Therapeutics Inc (ADGI) Be in Your Portfolio Wednesday?

Adagio Therapeutics Inc (ADGI) is near the middle in its industry group according to InvestorsObserver. ADGI gets an overall rating of 39. That means it scores higher than 39 percent of stocks. Adagio Therapeutics Inc gets a 57 rank in the Biotechnology industry. Biotechnology is number 112 out of 148 industries.

ADGI has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on ADGI!

See Full ADGI Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 39 would rank higher than 39 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Adagio Therapeutics Inc Stock Today?

Adagio Therapeutics Inc (ADGI) stock is trading at $5.59 as of 10:33 AM on Wednesday, Jan 19, a rise of $0.09, or 1.64% from the previous closing price of $5.50. The stock has traded between $5.36 and $5.65 so far today. Volume today is below average. So far 385,204 shares have traded compared to average volume of 14,460,226 shares. Click Here to get the full Stock Report for Adagio Therapeutics Inc stock.